Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021GlobeNewsWire • 03/02/21
Aptose Biosciences (APTO) Sees Hammer Chart Pattern: Time to Buy?Zacks Investment Research • 12/30/20
Aptose Shares Sell Off As The Market Wanted More Than Further Signs And PortentsSeeking Alpha • 12/08/20
Aptose Biosciences' (APTO) CEO William Rice on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020GlobeNewsWire • 10/27/20
Aptose to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech SummitGlobeNewsWire • 09/15/20
Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth ConferenceGlobeNewsWire • 08/06/20
Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020GlobeNewsWire • 07/21/20
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid LeukemiaGlobeNewsWire • 06/29/20